NCT01758042 Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders Status COMPLETED Phase NA
NCT01727973 Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy Status COMPLETED Phase PHASE1/PHASE2
NCT01656278 An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis Status COMPLETED Phase NA
NCT01611636 Clinical Characteristics of Allergy, Autoimmune and Rheumatic Diseases: A Ten Year Retrospective Study Status COMPLETED Phase N/A
NCT01601028 Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome Status COMPLETED Phase PHASE3
NCT01582880 Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis Status COMPLETED Phase PHASE1/PHASE2
NCT01579110 Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia. Status UNKNOWN Phase PHASE2
NCT01453764 Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple Sclerosis Status WITHDRAWN Phase NA
NCT01420133 Is a Diet Necessary When Corticosteroid Treatment is Prescribed? Status COMPLETED Phase NA
NCT01416350 A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With Azithromycin Status COMPLETED Phase PHASE1
NCT01351805 Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain Status COMPLETED Phase NA
NCT01351545 A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Status RECRUITING Phase N/A
NCT01210716 Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device Status COMPLETED Phase PHASE3
NCT01180868 The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases Status COMPLETED Phase N/A
NCT01093911 Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE1
NCT01056471 Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis Status COMPLETED Phase PHASE1/PHASE2
NCT01004432 Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA) Status COMPLETED Phase PHASE3